Researchers developed a computational model to optimize drug selection for chronic myelogenous leukemia (CML), tailoring ...

disease progression; allogeneic stem cell transplantation (alloSCT); and death. They calculated QALYs using health utility values specific to CML treatments based on previous studies, 7,8 ...

Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.

Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people ...

Therapeutic advances in CML have followed an increasing understanding of molecular mechanisms involved in disease progression or imatinib resistance. Despite the effectiveness of imatinib ...

Chronic myelogenous leukemia is a form of cancer that can be treated with stem cell transplation,but many patients manage without it, as long as they receive effective medications called thyrokinase ...

Enliven Therapeutics' ELVN-001 shows promising results for CML patients. Click here to read what makes ELVN stock a ...

Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people with a specific type of ...

Dorocubicel is under clinical development by ExCellThera and currently in Phase II for Blood Cancer. According to GlobalData, Phase II drugs for Blood Cancer have a 34% phase transition success rate ...

It’s common not to have any symptoms in the early stages of these diseases. Here’s a look at ... The outlook for CML has improved in recent years with the development of new medications.